StockData
ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31

Adlai Nortye Group Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026
$10.38−0.65 (-5.89%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

SEC filings

31 of Adlai Nortye's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report6-KOct 15, 2026Oct 15, 2026SEC EDGAR
Current report6-KSep 30, 2026Sep 30, 2026SEC EDGAR
Current report6-KSep 30, 2026Sep 30, 2026SEC EDGAR
Current report6-KSep 8, 2026Sep 8, 2026SEC EDGAR
Current report6-KAug 26, 2026Aug 26, 2026SEC EDGAR
Current report6-KAug 19, 2026Aug 19, 2026SEC EDGAR
Current report6-KAug 14, 2026Aug 14, 2026SEC EDGAR
Current report6-KAug 3, 2026Aug 3, 2026SEC EDGAR
Current report6-KJul 16, 2026Jul 17, 2026SEC EDGAR
Current report6-KApr 16, 2026Apr 16, 2026SEC EDGAR
Annual report20-FDec 31, 2025Apr 10, 2026SEC EDGAR
Current report6-KApr 1, 2026Apr 1, 2026SEC EDGAR
Current report6-KFeb 12, 2026Feb 12, 2026SEC EDGAR
Current report6-KFeb 3, 2026Feb 3, 2026SEC EDGAR
Current report6-KDec 29, 2025Dec 29, 2025SEC EDGAR
Current report6-KDec 29, 2025Dec 29, 2025SEC EDGAR
Current report6-KDec 3, 2025Dec 3, 2025SEC EDGAR
Current report6-KOct 22, 2025Oct 22, 2025SEC EDGAR
Current report6-KJul 9, 2025Jul 9, 2025SEC EDGAR
Current report6-KMay 30, 2025May 30, 2025SEC EDGAR
Annual report, amended20-F/ADec 31, 2024May 12, 2025SEC EDGAR
Annual report20-FDec 31, 2024Apr 30, 2025SEC EDGAR
Annual report, amended20-F/ADec 31, 2023Feb 14, 2025SEC EDGAR
Current report6-KFeb 14, 2025Feb 14, 2025SEC EDGAR
Current report6-KDec 31, 2024Dec 31, 2024SEC EDGAR
Current report6-KAug 8, 2024Aug 8, 2024SEC EDGAR
Current report6-KJul 3, 2024Jul 3, 2024SEC EDGAR
Current report6-KJun 27, 2024Jun 27, 2024SEC EDGAR
Current report6-KMay 23, 2024May 24, 2024SEC EDGAR
Annual report20-FDec 31, 2023Apr 19, 2024SEC EDGAR
Current report6-KApr 2, 2024Apr 2, 2024SEC EDGAR